Holen Sie sich die Stockscreener-App
96.40
0.52%
-0.50
Handel nachbörslich:
96.40
Schlusskurs vom Vortag:
$96.90
Offen:
$97.3
24-Stunden-Volumen:
463.12K
Relative Volume:
0.55
Marktkapitalisierung:
$5.82B
Einnahmen:
$521.31M
Nettoeinkommen (Verlust:
$-23.36M
KGV:
-201.63
EPS:
-0.4781
Netto-Cashflow:
$54.87M
1W Leistung:
-1.58%
1M Leistung:
+6.33%
6M Leistung:
+26.53%
1J Leistung:
+149.55%
1-Tages-Spanne:
$94.94
$97.37
1-Wochen-Bereich:
$92.77
$99.23
52-Wochen-Spanne:
$37.83
$109.28
Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile
Firmenname
Mirum Pharmaceuticals Inc
Sektor
Branche
Telefon
650-667-4085
Adresse
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
Compare MIRM vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MIRM
Mirum Pharmaceuticals Inc
|
96.40 | 5.85B | 521.31M | -23.36M | 54.87M | -0.4781 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-09-24 | Eingeleitet | TD Cowen | Buy |
| 2025-08-11 | Fortgesetzt | Stifel | Buy |
| 2025-05-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-04-17 | Eingeleitet | Stifel | Buy |
| 2023-12-18 | Bestätigt | H.C. Wainwright | Buy |
| 2023-11-20 | Fortgesetzt | JP Morgan | Overweight |
| 2023-11-13 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-10-17 | Fortgesetzt | Evercore ISI | Outperform |
| 2023-09-20 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-09-01 | Eingeleitet | Citigroup | Buy |
| 2021-09-20 | Eingeleitet | JP Morgan | Overweight |
| 2020-08-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2020-08-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-07-31 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-25 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-08-12 | Eingeleitet | Citigroup | Buy |
| 2019-08-12 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-12 | Eingeleitet | Guggenheim | Buy |
| 2019-08-12 | Eingeleitet | ROTH Capital | Buy |
| 2019-08-12 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Mirum Pharmaceuticals Inc Aktie (MIRM) Neueste Nachrichten
MIRM (NASDAQ: MIRM) files Rule 144: 2,000 shares via option exercise - Stock Titan
Is It Too Late To Consider Mirum Pharmaceuticals (MIRM) After Its Strong Multi‑Year Share Price Run? - Yahoo Finance
Mirum Pharmaceuticals reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView — Track All Markets
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
ETF Watch: What are analysts price targets for Mirum Pharmaceuticals IncMarket Trend Report & Consistent Profit Alerts - baoquankhu1.vn
Aug Movers: Does Mirum Pharmaceuticals Inc stock benefit from AI growthMarket Activity Summary & Stepwise Trade Signal Guides - baoquankhu1.vn
Prediction: Buying This Biotech Stock Today Could Set You Up for Life - Yahoo Finance
Cantor Fitzgerald Sticks to Their Buy Rating for Mirum Pharmaceuticals (MIRM) - The Globe and Mail
How Mirum Pharmaceuticals Inc. (MIRM) Affects Rotational Strategy Timing - Stock Traders Daily
Cantor Fitzgerald reiterates Mirum Pharmaceuticals stock rating By Investing.com - Investing.com Canada
Bluejay Therapeutics 2025 Financials: Mirum Pharmaceuticals Merger, Liquidity, and Key Financial Statements - Minichart
Mirum (MIRM) details Bluejay deal and $268.5M PIPE financing - Stock Titan
Primary Sclerosing Cholangitis Market is expected to Hit US$ - openPR.com
18,710 Shares in Mirum Pharmaceuticals, Inc. $MIRM Purchased by SG Americas Securities LLC - MarketBeat
Mirum Pharmaceuticals, Inc. (MIRM) Surpasses Q3 Earnings and Revenue Estimates - MSN
Mirum (MIRM) Q1 2025 Earnings Call Transcript - AOL.com
MIRM Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
MIRM PE Ratio & Valuation, Is MIRM Overvalued - Intellectia AI
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Mirum Pharmaceuticals, Inc. (MIRM) stock price, news, quote and history - Yahoo Finance UK
Why Is Mirum Pharmaceuticals (MIRM) Down 3.6% Since Last Earnings Report? - Eastern Progress
Mirum Pharmaceuticals, Inc. (MIRM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Mirum Pharmaceuticals (MIRM) Moves 5.1% Higher: Will This Strength Last? - qz.com
Mirum Pharmaceuticals (MIRM) Rises 5.1%: Can This Upward Momentum Continue? - Bitget
Mirum Pharma (MIRM) Earnings Call Transcript - The Globe and Mail
JPMorgan Chase & Co. Sells 380,067 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
(MIRM) and the Role of Price-Sensitive Allocations - Stock Traders Daily
US Stocks Recap: Will Mirum Pharmaceuticals Inc stock hit new highs in YEARWeekly Profit Report & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Does Mirum Pharmaceuticals Inc stock benefit from AI growth2026 Earnings & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
A Look At Mirum Pharmaceuticals (MIRM) Valuation After Strong Long Term Share Performance - Yahoo Finance
Hennion & Walsh Asset Management Inc. Sells 17,560 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Tudor Investment Corp ET AL Makes New $2.03 Million Investment in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Mirum Pharmaceuticals Stock: Pipeline Progress and Rare Disease Focus for Long-Term Investor Value - AD HOC NEWS
Energy Moves: Will Mirum Pharmaceuticals Inc benefit from AI trendsWeekly Market Summary & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Mirum Pharmaceuticals (MIRM) and NovoCure (NVCR) - The Globe and Mail
Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Raised to $125.00 - MarketBeat
Vanguard disaggregates holdings; Mirum (MIRM) shows 0 shares owned - stocktitan.net
Mirum Pharmaceuticals Insiders Sell US$1.6m Of Stock, Possibly Signalling Caution - 富途牛牛
TD Cowen raises Mirum Pharmaceuticals stock price target to $125 - Investing.com
TD Cowen Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $125 - Moomoo
Citizens reiterates Mirum Pharmaceuticals stock rating on HDV data By Investing.com - Investing.com Canada
Citizens reiterates Mirum Pharmaceuticals stock rating on HDV data - Investing.com
Investor Mood: What are analysts price targets for Mirum Pharmaceuticals Inc2026 Institutional Moves & High Accuracy Trade Alerts - baoquankhu1.vn
Mirum completes enrollment & screening in liver disease studies - MSN
Citizens reiterates Mirum Pharmaceuticals stock rating ahead of data By Investing.com - Investing.com Canada
Citizens reiterates Mirum Pharmaceuticals stock rating ahead of data - Investing.com
Mirum Pharmaceuticals (NASDAQ:MIRM) Receives Buy Rating from HC Wainwright - marketbeat.com
Mirum Gains 35% in 3 Months: How Should You Play the Stock? - MSN
Is Mirum Pharmaceuticals (NASDAQ:MIRM) Stabilizing After Rating Updates? - Kalkine Media
Mirum Pharmaceuticals (MIRM) completes enrollment for phase 3 EXPAND study of LIVMARLI - MSN
Finanzdaten der Mirum Pharmaceuticals Inc-Aktie (MIRM)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):